Molecular characterization and antimicrobial susceptibility for 62 isolates of Bordetella pertussis from children

Baohua He1, Zhaoyi Jia1, Fei Zheng2

  • 1Hebei Key Laboratory of Pathogens and Epidemiology of Infectious Diseases, HeBei Provincial Center for Disease Control and Prevention, Shijiazhuang, China.

Frontiers in Microbiology
|December 26, 2024
PubMed

Insights

Pertussis resurgence is linked to evolving Bordetella pertussis (BP) genotypes and antimicrobial resistance in China. This suggests a need to reevaluate pertussis immunization strategies and develop new vaccines to combat resistance.

Area of Science:

  • Microbiology
  • Genomics
  • Epidemiology

Background:

  • Pertussis, caused by Bordetella pertussis (BP), is a highly contagious respiratory illness.
  • Despite widespread immunization, pertussis incidence is rising globally, including in China.
  • Understanding circulating BP strains' genotypes and antibiotic resistance is crucial for control.

Purpose of the Study:

  • To investigate the genotypes and antimicrobial susceptibility of Bordetella pertussis strains from children in Hebei, China.
  • To analyze the genomic diversity and evolutionary traits of Chinese BP strains in a global context.

Main Methods:

  • Antimicrobial susceptibility testing (AST) and whole-genome sequencing (WGS) were performed on 62 BP isolates.
  • Multilocus sequence typing (MLST), multilocus antigen sequence typing (MAST), and multilevel genome typing (MGT) were employed.
  • Genomic data were compared with 313 international BP genomes.

Main Results:

  • Two dominant BP phylogenetic groups were identified, distinct from vaccine strains.
  • Significant erythromycin (56/62) and azithromycin (55/62) resistance was observed.
  • Erythromycin-resistant strains (Lineage I, MGT2 ST7) harbored the ptxP1 gene and 23S rRNA A2047G mutation.

Conclusions:

  • Antimicrobial resistance in BP may be linked to specific molecular types and evolutionary changes.
  • Selection pressures from antibiotics and immunization likely drive BP evolution in China.
  • Reevaluation of immunization strategies and development of novel vaccines are necessary to address pertussis resurgence and resistance.
Abstract